Pharmaceutical Innovation: Incentives, Competition, and Cost-benefit Analysis in International Perspective by Cambridge University Press (Hardback, 2007)
Brand newLOWEST PRICE
- AU $103.55+ AU $10.00 postage
- Brand new condition
- Sold by roxy*books
- See details for delivery est.
- AU $44.48+ AU $4.99 postage
- Good condition
- Sold by whattaplace
- See details for delivery est.
All listings for this product
Consider these sponsored items
Best-selling in Non-Fiction Books
Save on Non-Fiction Books
- AU $52.98Trending at AU $79.02
- AU $69.30Trending at AU $126.46
- AU $6.90Trending at AU $9.55
- AU $16.68Trending at AU $22.22
- AU $36.48Trending at AU $41.31
- AU $40.00Trending at AU $40.55
- AU $36.19Trending at AU $37.61
About this product
- DescriptionThe pharmaceutical industry worldwide is a rapidly burgeoning industry contributing to growth of gross domestic product and employment. Techlogical change in this field has been very rapid, with many new products being introduced. For this reason in part, health care budgets throughout the world have increased dramatically, eliciting growing pressures for cost containment. This book explores four important issues in pharmaceutical invations: (1) the industry structure of pharmaceutical invation; (2) incentives for correcting market failures in allocating resources for research and development; (3) competition and marketing; and (4) public evaluation of the benefits and costs of invation. The lessons are applicable to countries all over the world, at all levels of ecomic development. By discussing existing evidence this book proposes incentive arrangements to accomplish social objectives.
- Author BiographyFrank Sloan has been the J. Alexander McMahon Professor of Health Policy and Management and Professor of Economics at Duke University since 1993, where he holds faculty appointments in the Department of Economics, the School of Public Policy, the Fuqua School of Business, and the School of Nursing. Before joining the faculty at Duke, he was a research economist at the Rand Corporation and served on the faculties of the University of Florida and Vanderbilt University. His current research interests include alcohol use and smoking prevention, long-term care, medical malpractice, and cost-effectiveness analyses of medical technologies. Professor Sloan also has a long-standing interest in hospitals, health care financing, and health manpower. He has served on several national advisory public and private groups, including the Physician Payment Review Commission. He has been a member of the Institute of Medicine of the National Academy of Sciences since 1982, recently chairing IOM committees on vaccine financing and cancer in low- and middle-income countries. He recently received a Merit Award from the National Institutes of Health and an Investigator Award from the Robert Wood Johnson Foundation. Professor Sloan's most recent books include The Smoking Puzzle: Information, Risk Perceptions, and Choice (2003) with Drs V. Kerry Smith and Donald H. Taylor, Jr., and The Price of Smoking with Drs Jan Ostermann, Gabriel Picone, Christopher Conover, and Donald H. Taylor, Jr. (2004). Professor Sloan received his Ph.D. in economics from Harvard University in 1969. Chee-Ruey Hsieh is a Research Fellow in the Institute of Economics at Academia Sinica, Taipei, Taiwan. He received his Ph.D. in economics from Vanderbilt University in 1990. Dr Hsieh has a long-standing interest in health economics and health policy. He is the coeditor of two other books: The Economic Analysis of Substance Use and Abuse, and The Economics of Health Care in Asia-Pacific Countries.
- PublisherCambridge University Press
- Date of Publication30/04/2007
- SubjectIndustrial Studies: General
- Place of PublicationCambridge
- Country of PublicationUnited Kingdom
- ImprintCambridge University Press
- Content Note12 tables
- Weight602 g
- Width152 mm
- Height228 mm
- Spine26 mm
- Edited byChee-Ruey Hsieh,Frank A. Sloan
This item doesn't belong on this page.
Thanks, we'll look into this.